Award Recognizes HemoSonics’ Innovative Contributions and Exceptional Support in Advancing Diagnostic Hemostasis Solutions Across Premier’s Member Network...
Landmark trial to evaluate world’s first autonomous, electronic artificial urinary sphincter for stress urinary incontinence in men...
Pioneering Study Aims to Validate Convenient, Early Detection Method for Type 1 Diabetes Outside Clinical Settings...
Pioneering collaboration introduces next-generation automation to reproductive medicine, marking a breakthrough in accessible and standardized IVF care....
Next-Generation Platform Enhances Endoscopic Ultrasound Imaging to Support More Accurate and Efficient Diagnoses...
The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY....
Pivotal U.S. Trial Evaluates Safety and Effectiveness of Onyx™ for Managing Bleeding in Peripheral Vasculature...
Next-Generation Platforms Deliver High Throughput, Precision, and Workflow Optimization in Coagulation Testing...
New Platform Offers Three Genomic Tests to Tailor Treatment Strategies for Glioblastoma Patients ...
Next-generation embolic technology enables rapid resorption and improved patient comfort in minimally invasive neurointervention...
